We are live on ! Find out more
PFE icon

Pfizer
PFE

2,874 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,183 increasing their positions, 1,240 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 212 | Existing positions closed: 172

6% more funds holding in top 10

Funds holding in top 10: 31 → 33 (+2)

0% less funds holding

Funds holding: 2,875 → 2,874 (-1)

0% less capital invested

Capital invested by funds: $105B → $105B (-$332M)

5% less repeat investments, than reductions

Existing positions increased: 1,183 | Existing positions reduced: 1,240

1.16% less ownership

Funds ownership: 67.24% → 66.08% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,874
Holders Change
-1
Holders Change %
-0.03%
% of All Funds
41.5%
Holding in Top 10
33
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+6.45%
% of All Funds
0.48%
New
212
Increased
1,183
Reduced
1,240
Closed
172
Calls
$2.36B
Puts
$3.9B
Net Calls
-$1.54B
Net Calls Change
+$77.4M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$346M
2
Millennium Management
Millennium Management
New York
+$334M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M

Top Sellers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
-$675M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$437M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$313M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$222M
5
Deutsche Bank
Deutsche Bank
Germany
-$220M
Name Holding Trade Value Shares
Change 		Change in
Stake
HAG
951
HF Advisory Group
Maryland
$2.52M +$205K +7,429 +9%
ACP
952
Aviance Capital Partners
Florida
$2.51M -$53.3K -1,936 -2%
WAM
953
Werlinich Asset Management
Connecticut
$2.51M +$37.2K +1,350 +2%
IAS
954
Insigneo Advisory Services
Florida
$2.51M -$496 -18 -0%
IAG
955
Investmark Advisory Group
Connecticut
$2.5M +$43.7K +1,587 +2%
TNB
956
Thomasville National Bank
Georgia
$2.5M +$18.3K +666 +0.8%
CAAS
957
Capital Asset Advisory Services
Michigan
$2.49M +$70.8K +2,572 +3%
BG
958
Bellevue Group
Switzerland
$2.48M +$1.51M +54,780 +162%
SCA
959
Sippican Capital Advisors
Massachusetts
$2.47M +$152K +5,537 +7%
FMI
960
F/M Investments
District of Columbia
$2.46M +$2.42M +87,899 New
1SB
961
1ST Source Bank
Indiana
$2.46M -$1.14M -41,452 -32%
MFG
962
Merit Financial Group
Georgia
$2.44M -$365K -13,264 -13%
GAM
963
Griffin Asset Management
New York
$2.42M +$509K +18,480 +27%
UA
964
Unison Advisors
District of Columbia
$2.42M +$38K +1,380 +2%
SIA
965
Strategic Investment Advisors
Michigan
$2.41M +$20.2K +732 +0.9%
AUB
966
Atlantic Union Bankshares
Virginia
$2.41M -$81K -2,943 -3%
BMO
967
Beck Mack & Oliver
New York
$2.41M -$55.1K -2,000 -2%
NSAM
968
North Star Asset Management
Wisconsin
$2.39M -$762K -27,679 -24%
Edgewood Management
969
Edgewood Management
Connecticut
$2.38M – – –
DT
970
Diversified Trust
Tennessee
$2.37M -$835K -30,312 -26%
FNBOMD
971
First National Bank of Mount Dora
Florida
$2.37M -$971K -35,275 -29%
AWM
972
Allen Wealth Management
North Carolina
$2.36M -$46.1K -1,676 -2%
BIM
973
Bridges Investment Management
Nebraska
$2.36M +$1.05M +38,012 +82%
AWM
974
Avitas Wealth Management
California
$2.35M +$551K +20,001 +31%
PS
975
Principal Securities
Iowa
$2.35M +$142K +5,168 +7%
37 38
39
40 41

PFE Hedge Fund Activity: Q2 2024 in Review

2,874 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q2 2024, worth a combined $105B — down 0.32% from $105B a quarter earlier.

Buyers outnumbered sellers: 212 funds opened new PFE positions and 172 closed out — a net gain of 40 holders — while 1,183 added to existing stakes and 1,240 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $346M. The largest seller was Capital World Investors, cutting an estimated $675M.

  • 2,874 institutional investors held Pfizer (PFE) as of Q2 2024, down from 2,875 in Q1 2024.
  • Funds reported $105B of Pfizer stock for Q2 2024, down 0.32% quarter-over-quarter.
  • 212 funds opened new Pfizer positions in Q2 2024 and 172 closed out, a net change of +40 holders.
  • The largest Pfizer buyer in Q2 2024 was Goldman Sachs, an estimated $346M added.
  • The largest Pfizer seller in Q2 2024 was Capital World Investors, an estimated $675M sold.

Based on aggregated 13F filings for Q2 2024.